Company

CellSource Co. Ltd

Headquarters: Tokyo, Japan

Employees: 90

CEO: Mr. Masato Tsumamoto

JPX: 4880 -0.70%

Market Cap

¥13.32 Billion

JPY as of July 1, 2025

US$92.9 Million

Market Cap History

CellSource Co. Ltd Categories

Japan Healthcare Biotechnology
Japan Healthcare Japan Biotechnology

CellSource Co. Ltd market capitalization over time

Evolution of CellSource Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of CellSource Co. Ltd

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Stocks & Indices

CellSource Co. Ltd has the following listings and related stock indices.


Stock: JPX: 4880 wb_incandescent

Details

Headquarters:

1 Chome-19-5 Shibuya

Shibuya City

Tokyo, 150-0002

Japan

Phone: 81 3 6455 5308

Fax: 81 3 6455 5968